Death Benefit

Kobo ebook | December 27, 2011

byRobin Cook

not yet rated|write a review
Pia Grazdani is an exceptional yet aloof medical student working closely with Columbia University Medical Center’s premier scientist on cutting edge research that could revolutionize health care by creating replacement organs for critically ill patients. But when tragedy strikes in the lab, Pia, with the help of classmate George Wilson, launches an investigation into the unforeseen calamity in the hospital’s supposedly secure biosafety lab.

Meanwhile, two ex-Wall Street whiz-kids think they’ve found another loadstone in the nation’s multi-trillion dollar life insurance industry, and race to find ways to control actuarial data and securitize the policies of the aged and infirm to make another killing.

As Pia and George dig deeper into the events at the lab, one question remains unanswered: is someone attempting to manipulate private insurance information to allow investors to benefit from the deaths of others?

Pricing and Purchase Info

$10.99

Available for download
Not available in stores

From the Publisher

Pia Grazdani is an exceptional yet aloof medical student working closely with Columbia University Medical Center’s premier scientist on cutting edge research that could revolutionize health care by creating replacement organs for critically ill patients. But when tragedy strikes in the lab, Pia, with the help of classmate George Wilson...

Format:Kobo ebookPublished:December 27, 2011Publisher:Penguin Publishing GroupLanguage:English

The following ISBNs are associated with this title:

ISBN - 10:1101553677

ISBN - 13:9781101553671

Look for similar items by category:

Customer Reviews of Death Benefit

Reviews

Rated 4 out of 5 by from good read Overall this is a very good read. I just found part 1 to be a bit slow but once i got into part 2 the book flew by, If not for part 1 I would say its a must read
Date published: 2013-02-15
Rated 3 out of 5 by from The first half of the book was fascinating but... The first half of the book was very interesting and fascinating then it went blah. I completely lost interest half way through the book so I skipped to the ending. The book was an interesting look at what conflicts biotech can cause with life insurance and Wall Street (greed, evil greed).
Date published: 2012-01-20